Eam Global Investors LLC Pds Biotechnology Corp Transaction History

Eam Global Investors LLC

  • $435 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$3.28 - $13.2 $401,163 - $1.61 Million
122,306 New
122,306 $1.61 Million
Q4 2021

Feb 11, 2022
SELL
$7.76 - $14.35 $1.23 Million - $2.28 Million
-158,637 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$9.33 - $17.08 $273,023 - $499,812
-29,263 Reduced 15.57%
158,637 $2.36 Million
Q2 2021

Aug 13, 2021
BUY
$4.35 - $12.86 $817,364 - $2.42 Million
187,900 New
187,900 $2.36 Million

Others Institutions Holding PDSB

# of Institutions
65
Shares Held
4.05M
Call Options Held
253K
Put Options Held
70.4K
View Full List

About PDS Biotechnology Corp

PDSB Quotes by TradingView
  • Ticker PDSB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,458,700
  • Market Cap $41.5M
  • Description
  • PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...
More about PDSB
Track This Portfolio

Track Eam Global Investors LLC Portfolio

Follow Eam Global Investors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eam Global Investors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eam Global Investors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email